Centene said it is withdrawing its previously-issued 2025 GAAP and adjusted diluted earnings per share guidance, including the underlying guidance elements, according to a press release on July 1, 2025.

1. 01

   Centene said it is withdrawing its previously-issued 2025 GAAP and adjusted diluted earnings per share guidance, including the underlying guidance elements, according to a press release on July 1, 2025.

2. 02

   The company's preliminary analysis of Marketplace data from 22 states resulted in a reduction to its previous full-year net risk adjustment revenue transfer expectation by a preliminary estimate of approximately $1.8 billion, which corresponds to an adjusted diluted EPS impact of approximately $2.75.

3. 03

   Centene said Wakely's Marketplace data covers 22 of 29 Marketplace states, representing approximately 72% of the company's Marketplace membership, and the company does not have information or estimates for its remaining 7 Marketplace states but anticipates an additional reduction to its net risk adjustment revenue transfer expectation with a corresponding adjusted diluted EPS impact.

4. 04

   The company said its Medicaid business has experienced a step-up in medical cost trend in behavioral health, home health and high-cost drugs, and it expects the Q2 Medicaid Health Benefits Ratio to be higher than the Q1 Medicaid HBR, with second quarter Q2 results to be reported on July 25, 2025.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.